Select publications
Aschele C et al. Pre-operative FU-based chemoradiation +/- weekly oxaliplatin in locally advanced rectal cancer. Preliminary safety findings of the STAR (Studio Terapia Adiuvante Retto)-01 randomized trial. Proc ASCO GI Symposium 2007;Abstract 233.
Bosset JF et al; EORTC Radiotherapy Group Trial 22921. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006;355(11):1114-23. Abstract
Goldberg RM et al. Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/ leucovorin administered bimonthly in elderly patients with colorectal cancer. J Clin Oncol 2006;24(25):4085-91. Abstract
Mohiuddin M et al; Radiation Therapy Oncology Group Trial 0012. Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012. J Clin Oncol 2006;24(4):650-5. Abstract
Rödel C et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005;23(34):8688-96. Abstract
Ryan DP et al. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901. J Clin Oncol 2006;24(16):2557-62. Abstract
Sauer R et al; German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351(17):1731-40. Abstract
